Intracardiac lead having a compliant fixation device

• US 5,837,007 A
• Filed: 03/26/1997
• Issued: 11/17/1998
• Est. Priority Date: 12/19/1995
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Altman, Peter A., Bush, M. Elizabeth, Carson, Dean F.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US08/824,101
• Time in Patent Office: 601 Days
• Field of Search: 128/642, 607/119, 607/122, 607/126, 607/127, 607/123, 607/130, 607/131, 600/374, 600/375
• US Class Current: 607/127
• CPC Class Codes: A61N 1/0573 chacterised by means penetrating the heart tissue, e.g. helix needle or hook

Abstract

Intracardiac lead for compliant fixation of a distal end of the lead to cardiac tissue. A fixation helix is disposed at the distal end of the lead. The fixation helix has a first end rigidly attached to the compliant fixation device and a second end that is sharpened to facilitate insertion of the fixation helix into cardiac tissue. The fixation helix can be designed to provide for either electrically active or inactive fixation. Once the lead is implanted in the cardiac tissue, the compliant fixation device, connecting the lead with the fixation helix, reduces the amount of lead movement that is transferred to the patient'"'"'s tissue at the site of implantation of the fixation helix and reduces those forces from lead movement that could cause dislodgment of the fixation helix. The compliant fixation device thereby decreases the amount of irritation to the cardiac tissue, lessens the possibility of fibrous tissue growth around the area of the fixation helix, decreases the chance of dislodgment of the fixation helix, and reduces the possibility of perforation of the cardiac wall or tamponade of the pericardial sac.

Claims

1. A compliant fixation mechanism comprising:

a fixation helix for transvenously securing a lead to a patient'"'"'s cardiac tissue; and

a flexible connector attached between said fixation helix and said lead, said flexible connector reducing forces transferred between said fixation helix and said lead.

2. The compliant fixation mechanism of claim 1, wherein said flexible connector comprises a universal joint.

3. The compliant fixation mechanism of claim 1, wherein said flexible connector comprises:

a piston disposed in a distal end of the lead, said piston being longitudinally translatable within the lead and having a piston chamber formed therein, said piston chamber being filled with a flexible, biocompatible material; and

head means disposed within said flexible, biocompatible material within said piston chamber, wherein said head means is rigidly attached to a first end of said fixation helix.

4. The compliant fixation mechanism of claim 3, wherein said flexible, biocompatible material is bioreactive.

5. The compliant fixation mechanism of claim 1, wherein said flexible connector comprises:

a piston disposed for longitudinal translation within the lead; and

a thin, flattened section formed at a first end of said fixation helix, wherein said thin, flattened section can bend laterally and transversely, said thin, flattened section being fixedly connected to said piston.

6. The compliant fixation mechanism of claim 1, and further including means for temporarily stabilizing said flexible connector during transvenous securing of said lead.

13. A method of implanting the compliant fixation mechanism of claim 1 comprising the steps of:

(a) inserting said fixation helix into a chamber of the patient'"'"'s heart;

(b) temporarily stabilizing said flexible connector;

(c) while said flexible connector is stabilized, piercing the patient'"'"'s cardiac tissue with said fixation helix;

(d) while said flexible connector is stabilized, transmitting torque to said fixation helix to screw said fixation helix into the patient'"'"'s cardiac tissue; and

(e) after said fixation helix is screwed into the patient'"'"'s cardiac tissue, destabilizing said flexible connector.

14. The method of claim 13 wherein said step (b) comprises employing a bioreactive material to stabilize said flexible connector.

15. The method of claim 14 wherein said step (e) comprises allowing said bioreactive material to dissolve in the patient'"'"'s blood.

16. The method of claim 14 wherein said step (e) comprises allowing said bioreactive material to soften upon contact with the patient'"'"'s blood.

7. An intracardiac lead for transvenous implantation within a patient'"'"'s heart having cardiac tissue, comprising:

an electrode tip for delivering electrical energy to the patient'"'"'s heart, said electrode tip including means for transvenously securing said electrode tip to tissue within the patient'"'"'s heart;

a lead body for delivering electrical energy to said electrode tip; and

a flexible connector attached between said securing means and said lead body, said flexible connector reducing forces transferred between said lead body and said securing means.

8. The intracardiac lead of claim 7, wherein said flexible connector comprises a universal joint.

9. The intracardiac lead of claim 7, wherein said flexible connector comprises:

a piston disposed in the distal end of the lead, said piston being longitudinally translatable within the lead and having a piston chamber formed therein, said piston chamber being filled with a flexible, biocompatible material; and

head means disposed within said flexible, biocompatible material within said piston chamber, wherein said head means is rigidly attached to a first end of said securing means.

10. The intracardiac lead of claim 9, wherein said flexible, biocompatible material is bioreactive.

11. The intracardiac lead of claim 7, wherein said flexible connector comprises:

a piston disposed for longitudinal translation within the lead; and

a thin, flattened section formed at a first end of said securing means, wherein said thin, flattened section can bend laterally and transversely, said thin, flattened section being fixedly connected to said piston.

12. The intracardiac lead of claim 7, and further including means for temporarily stabilizing said flexible connector during transvenous securing of said electrode tip.

17. A method of implanting the intracardiac lead of claim 7 comprising the steps of:

(a) transvenously inserting said electrode tip within the patient'"'"'s heart;

(b) temporarily stabilizing said flexible connector;

(c) while said flexible connector is stabilized, transvenously securing said electrode tip to tissue within the patient'"'"'s heart; and

(d) after said electrode tip is secured within the patient'"'"'s heart, destabilizing said flexible connector.